In July 2023, we changed our name from AACC (short for the American Association for Clinical Chemistry) to the Association for Diagnostics & Laboratory Medicine (ADLM). The following page was written prior to this rebranding and contains mentions of the association’s old name. It may contain other out-of-date information as well.

2008 Award for Outstanding Contribution for a Publication in the International Journal Clinical Chemistry

Dr. Dihazi is associate professor, group leader of proteomics in the department of nephrology and rheumatology, and director of the clinical proteomics facility at the Georg-August University in Göttingen, Germany. His research focuses on key proteins connecting cellular stress response pathways to renal diseases. His group also seeks to develop new clinical proteomics approaches for earlier diagnosis of human diseases and biomarker discovery. Dr. Dihazi is a council member of the Human Kidney and Urine Proteomics Project and the European Kidney and Urine Proteomics Association. He is also the co-founder of the Göttingen Proteomics Forum. He is involved in several proteomics journals as an editorial board member and is editor-in-chief of Proteomics Insights. He has published a number of articles on proteomics, especially their relation to kidney function. In his winning article, “Characterization of diabetic nephropathy by urinary proteomic analysis: identification of a processed ubiquitin form as differentially excreted protein in diabetic nephropathy patients,” Dr. Dihazi described a robust procedure for the identification and characterization of proteins differentially excreted in the urine of diabetic patients with microalbuminuria and/or macroalbuminuria. He also identified indicators of tissue injury in urine that may result in clinical applications for early diagnosis of diabetes mellitus-related nephropathy. The paper’s co-authors were Gerhard A. Mueller, Sandra Lindner, Markus Meyer, Abdul R. Asif, Michael Oellerich, and Frank Strutz. Clin Chem 2007; 53:9, 1636-1645